Search results - 7 results
The European response to the WHO call cervical cancer as a public health problem
Issue 2 (2021) Keywords: cervical cancer screening COVID-19 elimination of cervical cancer Europe HPV vaccination WHO Abstract: The age‐standardised incidence of cervical cancer in Europe varies widely ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
resulted in substantial decreases in the burden of cervical cancer in western and northern Europe; but in eastern Europe, cervical cancer incidence and mortality remain comparatively high. Today, new ...
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Cancer incidence rates were computed for the target population (truncated to 25-64 years) and were age standardized according to the world reference population. World standardized incidence rates for the ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Volume 363 (2018) Keywords: Colposcopy Early Detection of Cancer Female Humans incidence Intention to Treat Analysis Mass Screening Papillomaviridae Papillomavirus Infections Randomized Controlled Trials ...
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.
Weiderpass, Elisabete Source: Int J Cancer, Volume 128, Issue 8, p.1899-907 (2011) Keywords: Adult Age factors Aged Baltic States Bulgaria Cohort Studies Female Humans incidence middle aged Neoplasm ...
Cytological screening for cervical cancer in the province of Limburg, Belgium.
with the cancer registry. The screening coverage (percentage of women with a Pap smear in a defined period), the prevalence and incidence of squamous intraepithelial lesions and changes over time and ...
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.
protective effect of HPV screening compared to cytology on the incidence of invasive cervical cancer is directly demonstrated in randomized trials. No protective effect is demonstrated under 30 years. The risk ...